596
Views
101
CrossRef citations to date
0
Altmetric
Review

Multicomponent reactions (MCR) in medicinal chemistry: a patent review (2010-2020)

, , , , , ORCID Icon & show all
Pages 267-289 | Received 14 May 2020, Accepted 30 Nov 2020, Published online: 29 Dec 2020

References

  • Domling A, Wang W, Wang K. Chemistry and biology of multicomponent reactions. Chem Rev. 2012;112(6):3083–3135.
  • Estevez V, Villacampa M, Menendez JC. Multicomponent reactions for the synthesis of pyrroles. Chem Soc Rev. 2010;39(11):4402–4421.
  • Ruijter E, Orru RV. Multicomponent reactions–opportunities for the pharmaceutical industry. Drug Discov Today Technol. 2013;10(1):e15–e20.
  • Cioc RC, Ruijter E, Orru RV. *Multicomponent reactions: advanced tools for sustainable organic synthesis. Green Chem. 2014;16(6):2958–2975.
  • Kumar D, Jadhavar PS, Nautiyal M, et al. ** Convenient synthesis of 2, 3-disubstituted quinazolin-4 (3 H)-ones and 2-styryl-3-substituted quinazolin-4 (3 H)-ones: applications towards the synthesis of drugs. RSC Adv. 2015;5(39):30819–30825 and reference therein.
  • Wang H-Y, Shi D-Q. ** Efficient synthesis of functionalized Dihydro-1 H-indol-4 (5 H)-ones via one-pot three-component reaction under catalyst-free conditions. ACS Comb Sci. 2013;15(5):261–266.
  • Khan AT, Khan MM, Bannuru KK. Iodine catalyzed one-pot five-component reactions for direct synthesis of densely functionalized piperidines. Tetrahedron. 2010;66(39):7762–7772.
  • Kumar D, Sonawane M, Pujala B, et al. ** Supported protic acid-catalyzed synthesis of 2, 3-disubstituted thiazolidin-4-ones: enhancement of the catalytic potential of protic acid by adsorption on solid supports. Green Chem. 2013;15(10):2872–2884.
  • Kumar D, Kommi DN, Bollineni N, et al. * Catalytic procedures for multicomponent synthesis of imidazoles: selectivity control during the competitive formation of tri-and tetrasubstituted imidazoles. Green Chem. 2012;14(7):2038–2049.
  • Roy SR, Jadhavar PS, Seth K, et al. Organocatalytic application of ionic liquids:[bmim][MeSO4] as a recyclable organocatalyst in the multicomponent reaction for the preparation of dihydropyrimidinones and-thiones. Synthesis. 2011;2011(14):2261–2267.
  • Tzitzikas TZ. Innovative multicomponent reactions and their use in medicinal chemistry. Groningen, Netherlands: University of Groningen; 2017.
  • Garbarino S, Ravelli D, Protti S, et al. Photoinduced multicomponent reactions. Angew Chem Int Ed. 2016;55(50):15476–15484.
  • Ruijter E, Scheffelaar R, Orru RV. * Multicomponent reaction design in the quest for molecular complexity and diversity. Angew Chem Int Ed. 2011;50(28):6234–6246.
  • Alvim HG, da Silva Junior EN, Neto BA. What do we know about multicomponent reactions? Mechanisms and trends for the Biginelli, Hantzsch, Mannich, Passerini and Ugi MCRs. RSC Adv. 2014;4(97):54282–54299.
  • Haji M. Multicomponent reactions: A simple and efficient route to heterocyclic phosphonates. Beilstein J Org Chem. 2016;12(1):1269–1301.
  • Gangjee A, inventor Google Patents, assignee. Bicyclic and tricyclic pyrimidine tyrosine kinase inhibitors with antitubulin activity and methods of treating a patient patent US 10385064 B2. 2015.
  • Nucci GD, inventor Pyridopyrimidines derivatives compounds patent US 2018/0111926 A2. 2018.
  • Blaszczyk R, Gzik A, Borek B, et al., inventors. Dipeptide piperidine derivatives patent US 2019/0300525 A1. 2019.
  • Hoock CM, Qadan A, Terhaag B, inventors. Multicomponent crystals made of (2-amino-6-(4-fluoro-benzylamino)- pyridin-3-yl-carbamic acid ethyl ester and anarylpropioncacid patent US 8962847 B2. 2015.
  • Marsais F, Levacher V, Papamicael C, et al., inventors; Google Patents, assignee. Oxidisable pyridine derivatives, their preparation and use as anti-alzheimer agents patent US 9376387 B2. 2016.
  • Moldes M, Pereira PB, Caamaño TC, et al., inventors. Pyridazin-3 (2H)-one derivatives as monoamine oxidase selective isoform B inhibitors patent US 10253000 B2. 2019.
  • Floreancig PE, Day BW, Wan S, et al., inventors; Google Patents, assignee. Pederin and psymberin agents patent US 9364555 B2. 2016.
  • Biju AT, Kaicharla T, Yetra SR, et al., inventors; Google Patents, assignee. Oxindole compounds, solvent-free synthesis and use thereof patent US 2016/0039755 A1. 2016.
  • Chakraborti AK, Kumar D, Sharma H, inventors. An improved process for one-pot synthesis of 2-Styryl-4-(3H)-quinazolinones patent 305128. 2011.
  • Frackenpohl J, Zeiss IH-J, Heinemann I, et al., inventors; Google Patents, assignee. Use of substituted isoquinolinones, isoquinolindiones, isoquinolintriones and dihydroisoquinolinones or in each case salts thereof as active agents against abiotic stress in plants patent US 9173395 B2. 2015.
  • Doemling A, inventor Google Patents, assignee. Substituted heterocycles as therapeutic agents for treating cancer patent US 2013/0211079 A1. 2013.
  • Corminboeuf O, Cren S, Leroy X, et al., inventors; Google Patents, assignee. Benzimidazolyl-methyl urea derivatives as ALX receptor agonists patent US 9663473 B2. 2017.
  • Vardanyan R, Hruby V. Synthesis of essential drugs. Netherlands: Elsevier; 2006.
  • Palomo C, Aizpurua JM, Ganboa I, et al. Asymmetric synthesis of β‐lactams by staudinger ketene‐imine cycloaddition reaction. Eur J Org Chem. 1999;1999(12):3223–3235.
  • Rosenblum SB, Huynh T, Afonso A, et al. Discovery of 1-(4-fluorophenyl)-(3 R)-[3-(4-fluorophenyl)-(3 S)-hydroxypropyl]-(4 S)-(4-hydroxyphenyl)-2-azetidinone (SCH 58235): a designed, potent, orally active inhibitor of cholesterol absorption. J Med Chem. 1998;41(6):973–980.
  • Wang K, Kim D, Domling A. Cyanoacetamide MCR (III): three-component Gewald reactions revisited. J Comb Chem. 2010;12(1):111–118.
  • Gewald K, Schinke E, Böttcher H. Heterocyclen aus CH‐aciden nitrilen, VIII. 2‐amino‐thiophene aus methylenaktiven nitrilen, carbonylverbindungen und Schwefel. Chem Ber. 1966;99(1):94–100.
  • Sisko J. A one-pot synthesis of 1-(2, 2, 6, 6-tetramethyl-4-piperidinyl)-4-(4-fluorophenyl)-5-(2-amino-4-pyrimidinyl)-imidazole: a potent inhibitor of P38 MAP kinase. J Org Chem. 1998;63(13):4529–4531.
  • Van Leusen AM, Wildeman J, Oldenziel OH. Chemistry of sulfonylmethyl isocyanides. 12. Base-induced cycloaddition of sulfonylmethyl isocyanides to carbon, nitrogen double bonds. Synthesis of 1, 5-disubstituted and 1, 4, 5-trisubstituted imidazoles from aldimines and imidoyl chlorides. J Org Chem. 1977;42(7):1153–1159.
  • Kuethe JT, Gauthier DR, Beutner GL, et al. Synthesis of (S)-N-Ethoxycarbonyl-α-methylvaline. J Org Chem. 2007;72(19):7469–7472.
  • Riva R, Banfi L, Basso A, et al. Synthesis of tricyclic N-heterocycles coupling an ugi reaction with a tandem SN2′-heck double cyclization. J Org Chem. 2010;75(15):5134–5143.
  • Lamberth C, Jeanguenat A, Cederbaum F, et al. Multicomponent reactions in fungicide research: the discovery of mandipropamid. Bioorg Med Chem. 2008;16(3):1531–1545.
  • Vázquez-Romero A, Cárdenas L, Blasi E, et al. Synthesis of prostaglandin and phytoprostane B1 via regioselective intermolecular Pauson− Khand reactions. Org Lett. 2009;11(14):3104–3107.
  • Chen W, Mbafor W, Roberts SM, et al. A very simple, highly stereoselective and modular synthesis of ferrocene-based P-chiral phosphine ligands. J Am Chem Soc. 2006;128(12):3922–3923.
  • Chen W, Roberts SM, Whittall J, et al. An efficient and highly stereoselective synthesis of new P-chiral 1,5-diphosphanylferrocene ligands and their use in enantioselective hydrogenation. Chem Commun. 2006;27:2916–2918. DOI:10.1039/b601952h
  • Almássy A, Rakovský E, Malastová A, et al. Synthesis of epimer of Taniaphos ligand. J Organomet Chem. 2016;805:130–138.
  • a) Ugi, I., Steinbrückner, C. 1959, DE-B1, 103, 337 ; b) Ugi, I.; Meyr, R.; Fetzer, U. Angew Chem Int Ed. 1959;71:386.
  • Zhang L, Peng XM, Damu GL, et al. Comprehensive review in current developments of imidazole-based medicinal chemistry. Med Res Rev. 2014;34(2):340–437.
  • Boltjes A, Dömling A. The Groebke‐Blackburn‐Bienaymé reaction. Eur J Org Chem. 2019;2019(42):7007–7049.
  • Shaaban S, Abdel-Wahab BF. Groebke–Blackburn–Bienaymé multicomponent reaction: emerging chemistry for drug discovery. Mol Divers. 2016;20(1):233–254.
  • Znabet A, Polak MM, Janssen E, et al. A highly efficient synthesis of telaprevir by strategic use of biocatalysis and multicomponent reactions. Chem Commun. 2010;46(42):7918–7920.
  • a) Zarganes-Tzitzikas T, Dömling A. Modern multicomponent reactions for better drug syntheses. Org Chem Front. 2014;1(7):834–837; b) Chandgude A. Multicomponent reactions: development, scope, and applications. Groningen, Netherlands 2017.
  • Moni L, Banfi L, Basso A, et al. Ugi and Passerini reactions of biocatalytically derived chiral aldehydes: application to the synthesis of bicyclic pyrrolidines and of antiviral agent telaprevir. J Org Chem. 2015;80(7):3411–3428.
  • Cao H, Liu H, Dömling A. Efficient multicomponent reaction synthesis of the schistosomiasis drug praziquantel. Chem Eur J. 2010;16(41):12296–12298.
  • Thankappan BA, Bhunia A, Roy T, inventors. Spiro-oxazines, indolinones and preparation thereof patent US9617280B2. 2017.
  • Pang M-L, Zhang H-J, Liu -P-P, et al. One-pot synthesis of photochromic 6′-amino-substituted spirooxazines from 1-Nitroso-2-naphthol zinc chelate and indoline base. Synthesis. 2010;2010(20):3418–3422.
  • Rehn S, Bergman J, Stensland B. The three‐component reaction between Isatin, α‐Amino Acids, and Dipolarophiles. Eur J Org Chem. 2004;2004(2):413–418.
  • Sharma A, Sinha AK, Kumar R, et al., inventors. One pot multicomponent synthesis of some novel hydroxy stilbene derivatives with alpha, beta-carbonyl conjugation under microwave irradiation patent 8,716,532. 2014.
  • Rossiter SE, Fletcher MH, Wuest WM. Natural products as platforms to overcome antibiotic resistance. Chem Rev. 2017;117(19):12415–12474.
  • Hinzen B, Raddatz S, Paulsen H, et al. Medicinal chemistry optimization of acyldepsipeptides of the enopeptin class antibiotics. ChemMedChem. 2006;1(7):689–693.
  • Moreno-Cinos C, Goossens K, Salado IG, et al. ClpP protease, a promising antimicrobial target. Int J Mol Sci. 2019;20(9):2232.
  • Sello JK, inventor. Enopeptins, uses thereof, and methods of synthesis thereto patent US10106580B2. 2018.
  • Campbell JW, Cronan JJE. Bacterial fatty acid biosynthesis: targets for antibacterial drug discovery. Annu Rev Microbiol. 2001;55(1):305–332.
  • Johnson M, Christie S, Ghosh A, et al., inventors; Google Patents, assignee. Enoyl reductase inhibitors with antibacterial activity patent US 2015/0246888 A1. 2015.
  • Fleming FF, Pitta BR, inventors. Composition, synthesis, and use of isonitriles patent US8269032B1. 2012.
  • Rabot R, Bedjeguelal K, Kaloun EB, et al. inventors. Tri-and tetracyclic pyrazolo [3, 4-B] pyridine compounds as antineoplastic agent patent US9085575B2. 2015.
  • Biju AT, Bhunia A, Kaicharla T, inventors. Benzoxaphosphole compounds and a process for preparation thereof patent US Patent 9902746B2. 2018.
  • Biju AT, Bhunia A, Shanmugam D, inventors. Derivatives of benzoxazino quinoline, benzoxazino isoquinoline and processes for their preparation patent US9206196B1. 2015.
  • Ruijter E, Orru R, Znabet A, et al., inventors. Process for the preparation of alpha-acyloxy beta-formamido amides patent US20140213788A1. 2014.
  • Accetta A, Rancati F, Capelli AM, et al. inventors. Bicyclic dihydropyrimidine-carboxamide derivatives as Rho-Kinase inhibitors patent US20180170939A1. 2020.
  • Al-Zaydia KM, Alqahtani NF, Al-Boqamia M, et al., inventors. Dihydropyrimidones and pharmaceutical compositions thereof patent US10358425B1. 2019.
  • Bilbao JIB, Closa JT, Cazorla RPDLB, et al., inventors; Google Patents, assignee. 4-amino-6-(2, 6-dichlorophenyl)-2-(phenylamino)-pyrido [2, 3-d] pyrimidin-7 (8H)-one derivatives, synthesis and uses thereof patent US 9630962 B2. 2017.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.